| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |